This page shows the latest Relvar news and features for those working in and with pharma, biotech and healthcare.
Aside from Breo ( known as Relvar outside the US), Elan will get royalties on sales of COPD combination therapy Anoro ( umeclidinium bromide and vilanterol), vilanterol as a monotherapy and GSK961081, a
The combination is currently being considered by European regulatory authorities and if approved GSK plans to sell it as Relvar.
All three drugs will be delivering via GSK's Ellipta inhaler, which is already used in the company's recently introduced dual therapies Anoro ( umeclidinium and vilanterol) and Relvar/Breo ( fluticasone furoate and vilanterol).
SMC: Celgene's Abraxane 'too expensive' for Scotland. But medicines watchdog backs Sovaldi, Invokana, Defitelio, Relvar Ellipta. ... Drugs that received positive opinions included Janssen's Invokana ( canagliflozin) for type 2 diabetes, Jazz
Strengthens respiratory platform ahead of patent expiry for Advair/Seretide
First-quarter turnover came in at £5.6bn ( $9.5bn), with Advair sliding 15 per cent to £1.04bn - dragging down US sales by 10 per cent - while Breo ( known as Relvar in some
More from news
Approximately 2 fully matching, plus 18 partially matching documents found.